399
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Urinary Biomarkers as Indicators of Renal Disease

, , , , , , & show all
Pages 241-249 | Published online: 07 Jul 2009

References

  • Wedeen R P. Concentrative transport in human renal biopsies. Am J Med 1977; 62: 243–251
  • Friberg L. Proteinuria and kidney injury among workmen exposed to cadmium and nickel dust. J Indust Hyg Toxicol 1948; 30: 32–36
  • Yaqoob M, McClelland P, Patrick A W, et al. Tubular damage in microalbuminuric patients with primary glomerulonephritis and diabetic nephropathy. Renal Failure 1995; 17: 43–49
  • Maruhn D, Paar D, Bock K D. Lysosomal and brush border membrane enzymes in urine of patients with renal artery stenosis and with essential hypertension. Clin Biochem 1979; 12: 228–230
  • Sesso R, Retorri R, Nishida S, et al. Assessment of lupus activity using urinary retinal-binding protein. Nephrol Dial Transplantation 1994; 2: 367–371
  • Jung K, Diego J, Srobelt V. Diagnostic significance of urinary enzymes in detecting acute rejection crises in renal; transplant recipients depending on expression of results illustrated through the example of alanine aminopeptidase. Clin Biochem, 18: 257–260
  • Jung K A, Hempel K D, Grutzmann R D, et al. Age dependent exertion of alanine aminopeptidase, alkaline phosphatase, λ-glutamyl transferase and N-acetyl-β-D-glucosaminidase in human urine. Enzyme 1990; 43: 10–16
  • Maruhn D, Fuchs I, Mues G, et al. Normal limits of urinary excretion of eleven enzymes. Clin Chem 1976; 22: 1567–1574
  • Jung K, Pergande M, Forstmann B, et al. Diuresis-dependent excretions of low molecular weight proteins in urine: β2-microglobulin, lysozyme and ribonuclease. Scand J Clin Lab Invest 1998; 48: 33–37
  • Rossi R MS, Wurster C KU, Kulpmann W R, et al. Estimation of ifosfamide/cisplatinum-induced renal toxicity by urinary protein analysis. Pediatric Nephrology 1994; 8: 151–156
  • DeMarchi S, Cecchin E, Basile A, et al. Renal tubular dysfunction in chronic alcohol abuse - effects of abstinence. N Engl J Med 1993; 329: 1927–1934
  • Feldman D, Flandrois C, Jardel A. Circadian variations and reference intervals for some enzymes in urine of healthy children. Clin Chem 1989; 35: 864–887
  • Maruhn D, Strozyk K, Gielow L, et al. Diurnal variations of urinary enzyme excretion. Clin Chem Acta 1977; 75: 427–433
  • Cardenas A, Roels H, Bernard A M, et al. Markers of early renal changes induced by industrial pollutants. I. Applicantion to workers exposed to mercury vapour. Brit J Ind Med 1993; 50: 17–27
  • Cardenas A, Roels H, Bernard A M, et al. Markers of early renal changes induced by industrial pollutants. II Application to workers exposed to lead. Brit J Ind Med 1993; 50: 28–36
  • Mutti A, Alinovi R, Bergamaschi E, et al. Nephropathies and exposure to perchloroethylene in dry cleaners. Lancet 1992; 340: 189–193
  • Roels H, Lauwerys R, Buchet J P, et al. Comparison of renal function and pyschomotor performance in workers exposed to elemental mercury. Int Arch Occup Environ Health 1982; 50: 77–93
  • Bernard A, Lauwerys R. Epidemiological application of early markers of nephrotoxicity. Toxicology Lett 1989; 5: 293–306
  • Chia K S, Mutti A, Tan C, et al. Urinary N-acetyl-β-D-glucosaminidase activity in workers exposed to inorganic lead. Occ Environ Med 1994; 51: 125–129
  • Lin J L, Yeh K H, Tseng H C, et al. Urinary N-acetyl-β-D-glucosaminidase excretion and environmental lead exposure. Am J Nephrol 1993; 13: 442–447
  • Meyer B R, Fishbein A, Rosenman K, et al. Increased urinary enzymes excretion in workers exposed to nephrotoxic chemicals. Am J Med 1984; 76: 989–998
  • Pergande M, King K, Prescht S, et al. Changes excretion of urinary proteins and enzymes by chronic exposure to lead. Nephrol Dial Transplantation 1994; 9: 613–618
  • Verberk M M, Willems T EP, Verplanke A JW, et al. Environmental lead and renal effects in children. Arch Environ Health 1996; 51: 83–87
  • Vershoor M A, Wibowo R, Herbes J V, et al. Influence of low-level lead exposure on renal parameters. Am J Med 1987; 12: 341–351
  • Kabanda A, Jadoul M, Lauwerys R, et al. Low molecular weight proteinuria in chines herbs nephropathy. Kidney Int 1995; 48: 1571–1576
  • Wedeen R P. Occupational and environmental renal disease. Semin Nephrol 1997; 17: 46–54
  • Burke T, Faglano J, Goldoft M, Hazen R E, Iglewicz, McKee T. Chromite ore processing residue in Hudson County, New Jersey. Environ Health Perspectives 1991; 92: 131–138
  • Wedeen R P, Haque S, Udasin I, et al. Absence of tubular proteinuria following environmental exposure to chromium. Arch Environ Health 1996; 51: 321–323
  • Tucker S M, et al. Automated assay of NAG in normal and pathological urine. Clin Chim Acta 1975; 62: 333–339
  • Verpooten O F, Nouven E, Hoylaerts M F, et al. Segment-specific localisation of intestinal-type alkaline phosphatase in human kidney. Kidney Int 1989; 36: 617–625
  • Bernard A, Lauwerys R. Continuous flow system for the automation of latex immunoassay by particle counting. ClinChim 1983; 29: 1007–1011
  • Orloff K G, Ulrisch G, Wilder L, et al. Human exposure to elemental mercury in a contaminated residential building. Arch Environ Health 1997; 52: 169–172
  • Taylor S A, Chivers I D, Price R G, et al. The assessment of the utility of biomarkers to detect nephrotoxicity using an integrated database. Environ Res 1997; 75: 23–33
  • Langworth S, Almkvist O M, Soderman E, et al. Effects of occupational exposure to mercury vapour on the central nervous. system. Brit J Indust Med 1992; 49: 5454–5555
  • Roels H, Bernard A M, Cardenas A, et al. Markers of early renal changes induced by industrial pollutants. III application to workers exposed to cadmium. Brit J Indust Med 1993; 50: 37–48
  • Wedeen R P, Udasin I, Fiedler N, et al. Urinary N-acetyl-β-D-glucosaminidase (NAG) reflects current rather than cumulative lead exposure. Nephrology. Abstract International Society Nephrology, SydneyAustralia May 24-29, 1997; Suppl: S224
  • dos Santos A C, Colacciopo S, Dal Bo N AG, et al. Occupational exposure to lead, kidney function tests and blood pressure. Am J Industry Med 1994; 26: 635–643

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.